Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions

Annals of Pharmacotherapy

Volumn 35, Issue 11, 2001, Pages 1332-1338

  Peloquin, C A ^a   Zhu, M ^a   Adam, R D ^a   Singleton, M D ^a   Nix, D E ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Para aminosalicylic acid; Pharmacokinetics

Indexed keywords

AMINOSALICYLIC ACID; ANTACID AGENT; CLOFAZIMINE; CYCLOSERINE; ETHIONAMIDE; PYRIDOXINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG GRANULE; DRUG SAFETY; FEMALE; FOOD DRUG INTERACTION; FRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID DIET; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; URINALYSIS;

EID: 0034766403     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A088     Document Type: Article

References (12)

1. Treatment of tuberculosis infection in adults and children
2. Antimycobacterial agents: p-aminosalicylic acid
3. Pharmacokinetic evaluation of para-aminosalicylic acid granules
4. Once-daily and twice-daily dosing of p-aminosalicylic acid (PAS) granules
5. Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids
6. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids
7. Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids
8. Prediction of creatinine clearance from serum creatinine
9. Bioequivalence and bioequivalence testing
10. Bioavailability and bioequivalence requirements